logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Man Li

长沙医学院
H指数:10
被引数:485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Construction of efficacy prediction model for T-DXd treatment of HER2-positive and HER2-low expression breast cancer based on hematological indicators: A real-world study

基于血液学指标构建T-DXd治疗HER2阳性及HER2低表达乳腺癌疗效预测模型：一项真实世界研究

Computational Biology and Chemistry
IF3.1
2026-09-010
PRE
Su, Yanfang; Sang, Die; Zhang, Guoyong; Liu, Haiyan; Zhang, Yurong; Fan, Shanmin; Zhang, Jintao; Li, Shiyu; Zhang, Yanyan; Feng, Huachao; Zhao, Meiqing; Zhao, Longmei; Yuan, Peng; He, Binsheng; Li, Man
Prevalence, genetic variations and clinical outcomes of BRAF-V600 mutated advanced NSCLC in China: a retrospective real-world multi-centre study

中国BRAF-V600突变晚期非小细胞肺癌的患病率、遗传变异和临床结局：一项回顾性真实世界多中心研究

EBIOMEDICINE
IF10.8
2025-04-010
PRE
Jia, Bo; Wang, Shuo; Zhang, Fengyuan; Wang, Ziping; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Yang, Xue; Chen, Hanxiao; Chi, Yujia; Wang, Jingjing; Zhai, Xiaoyu; Nuersulitan, Reyizha; Wang, Xi; Tai, Yidi; Liu, Yiliang; Guan, Guohui; Zhao, Yanbin; Wang, Yudong; Zhang, Mengmeng; Liu, Xiuju; Liu, Lin; Li, Honglin; Wang, Yanlei; Shen, Fengqian; Liu, Zhiliang; Wang, Zhen; Man, Li; Zhang, Jiwei; Shi, Minmin; Li, Yong; Jiang, Caihong; Yan, Jingjing; Jin, Xin; Jin, Bo; Zhao, Jun
Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study

曲妥珠单抗德鲁替康在中国HER2阳性及HER2低表达晚期乳腺癌患者中的有效性与安全性：一项多中心、观察性、真实世界研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-280
OA
Die Sang; Yanfang Su; Yurong Zhang; Yanfeng Guan; Shanmin Fan; Jintao Zhang; Lijun Zheng; Yanling Wang; Ying Guo; Zixuan Lei; Man Li; Peng Yuan
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer
FUTURE ONCOLOGY
IF2.6
2024-12-040
OAAI
Jiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Toripalimab联合nab-紫杉醇治疗转移性或复发性三阴性乳腺癌: 一项随机3期试验

NATURE MEDICINE
IF50
2024-01-0827
PRE
Jiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition)
JOURNAL OF THE NATIONAL CANCER CENTER
IF9.4
2023-12-011
OAAI
Bu, Hong; Fan, Ying; Fan, Zhaoqing; Hu, Xichun; Li, Man; Li, Qiao; Liao, Ning; Luo, Ting; Nie, Jianyun; Pan, Yueyin; Qi, Xiaowei; Shao, Zhimin; Song, Guohong; Sun, Tao; Teng, Yue-e; Tong, Zhongsheng; Wang, Jiayu; Wang, Shusen; Wang, Xue; Wang, Yongsheng; Wang, Zhonghua; Xu, Binghe; Xu, Ling; Xue, Yan; Yang, Wentao; Yao, Herui; Ying, Jianning; Yuan, Peng; Zhang, Jian; Zhan, Qingyuan; Zhang, Yongqiang; Zhao, Jiuda
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study

MONARCH plus: abemaciclib加内分泌治疗HR /HER2-advanced乳腺癌女性: 多国随机III期研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2020-10-2271
OAAI
Zhang, Qing Yuan; Sun, Tao; Yin, Yong Mei; Li, Hui Ping; Yan, Min; Tong, Zhong Sheng; Oppermann, Christina P.; Liu, Yun Peng; Costa, Romulo; Li, Man; Cheng, Ying; Ouyang, Qu Chang; Chen, Xi; Liao, Ning; Wu, Xin Hong; Wang, Xiao Jia; Feng, Ji Feng; Hegg, Roberto; Kanakasetty, G. B.; Coccia-Portugal, Maria A.; Han, Ru Bing; Lu, Yi; Chi, Hai Dong; Jiang, Ze Fei; Hu, Xi Chun

研究方向

暂未获取到该数据
Z
Zuowei Zhao
H 指数:19论文数:73被引数:1,258
S
Shouling Wu
H 指数:68论文数:875被引数:5.5万
Y
Yueyin Pan
H 指数:45论文数:286被引数:1.0万
Y
Yongqiang Zhang
H 指数:28论文数:179被引数:2,370
Y
Yuee Teng
H 指数:31论文数:144被引数:2,737
Y
Yongsheng Wang
H 指数:27论文数:172被引数:2,637
J
Jiuwei Cui
H 指数:58论文数:641被引数:1.6万
K
Kangsheng Gu
H 指数:37论文数:261被引数:8,281
A
Anqin Zhang
H 指数:12论文数:69被引数:695
张丽丽 封面图
张丽丽
H 指数:37论文数:307被引数:7,183